Home>Products>Antibody engineering

Antibody engineering

In recent years, therapeutic antibody drugs have become one of the fastest growing fields in the biopharmaceutical industry. With the development of technology, various forms of engineered antibodies have been constructed to improve their performance, including affinity maturation, Fc engineering, humanization, bispecific or multi-specific antibodies (CrossMab, BiTE, etc.), chimeric antigen receptors (CAR), etc.

Product targets

Humanized monoclonal antibodies
  • bi-specific antibody molecule

Free trial available! Click to apply!

By using the DimAb® antibody development platform and in combination with the predictive bioinformatic analysis, DIMA Biotechnology can provide services for therapeutic antibody drug development, including rabbit antibody humanization, CAR and bispecific antibody molecule construction, etc.


Address Room 411-6, Building 2, No. 8, Jinfeng Road, High tech Zone, Suzhou



Follow Us On